Stryker hip replacement settlements have resolved thousands of cases involving recalled Rejuvenate and AGB II Modular-Neck hip stems. Individuals who suffered complications allegedly associated with certain Stryker LFIT Anatomic CoCr V40 Femoral Heads may also be entitled to compensation for their pain and suffering.
Bernstein Liebhard LLP has successfully represented hundreds of Rejuvenate and AGB II recipients who were able obtain compensation via Stryker hip lawsuits. Our attorneys are also investigating legal claims related to the Stryker FIT V40 hip recall. If you are interested in pursuing a similar lawsuit, please call (888) 994-5118 to learn more about your legal options.
A Stryker hip recall was announced in 2012 for thousands of Rejuvenate and ABG II Modular-Neck hip stems due to a potential for fretting and corrosion at the modular-neck junction. According to Stryker, this defect could result in adverse local tissue reactions, pain, swelling and premature failure of the hip. It is estimated that some 20,000 Rejuvenate and ABG II stems had been sold by the time the components were removed from the market. Thousand of lawsuits were eventually filed on behalf of individuals who allegedly experienced complications associated with the recall.
The majority of Stryker hip lawsuits related to the Rejuvenate and AGB II recall were centralized in litigations that had been established in the U.S. District Court, District of Minnesota, as well as New Jersey’s Bergen County Superior Court. The New Jersey litigation embarked on a pilot mediation program that produced several Stryker hip replacement settlements in individual cases. Then in November 2014, Stryker agreed to pay $1.43 billion to resolve thousands of pending claims.
The Stryker settlement program provided for gross base awards of $300,000 per failed implant, with potential deductions and enhancements based on the particulars of each case. Initially, the program was limited to individuals who had undergone revision surgery for a recall-related reason as of November 3, 2014, as well as patients who required revision but who were medically unable to undergo the procedure. In December 2016, Stryker agreed to expand the settlement program to include Rejuvenate and AGB II recipients who had undergone a recall-related revision as of December 19, 2016.
In August 2016, Stryker issued an “Urgent Medical Device Product Field Action Notification” to announce a recall for certain large-diameter LFIT V-40 Femoral Heads in the U.S., Australia and Canada. The affected devices were manufactured before 2011, and had been associated with reports of taper lock failure. Such an occurrence could lead to:
While a number of lawsuits have been filed by plaintiffs who received components included in the LFIT V-40 Femoral Head recall, the litigation has not yet resulted in any Stryker hip replacement settlements.
Bernstein Liebhard LLP provides free, no-obligation case reviews to individuals who allegedly suffered serious complications related to defective Stryker hip implants. To learn more, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.